Skip to main content Accessibility help
  • Print publication year: 2010
  • Online publication date: December 2010

Chapter 12 - In vitro maturation


Male reproductive dysfunction is the sole or contributory cause in half of infertile couples. Some health issues are more prevalent in infertile men and must be sought and the opportunity taken to assess and improve general and sexual health. Spontaneous conception may occur in many couples with male factor subfertility. In counseling patients, the severity of the male's reproductive problem, the duration of unprotected intercourse, and its frequency and timing, and the female partner's age and reproductive status are all important variables. There is a substantial background rate of spontaneous conception in subfertile men such that about 30% of couples with sperm densities of 1-5 million/ml as the only apparent fertility issue, achieved pregnancy over a two- to three-year period. Depending on the couple's age and reproductive history, some couples are happy to delay treatment in the hope that they will conceive while others express a wish for immediate intervention.


1. TanSL, RoystonP, CampbellS, et al. Cumulative conception and livebirth rates after in-vitro fertilisation. Lancet 1992; 339: 1390–4.
2. MacDougallMJ, TanSL, BalenA, JacobsHS. A controlled study comparing patients with and without polycystic ovaries undergoing in-vitro fertilization. Hum Reprod 1993; 8: 233–7.
3. ChaKY, KooJJ, KoJJ, et al. Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program. Fertil Steril 1991; 55: 109–13.
4. ChianRC, GülekliB, BuckettWM, TanSL. Priming with human chorionic gonadotropin before retrieval of immature oocytes in women with infertility due to the polycystic ovary syndrome. N Engl J Med 1999: 18: 1624–6.
5. ChianRC, BuckettWM, TulandiT, TanSL. Prospective randomized study of human chorionic gonadotrophin priming before immature oocyte retrieval from unstimulated women with polycystic ovarian syndrome. Hum Reprod 2000; 15: 165–70.
6. TanSL, ChildTJ, GulekliB. In vitro maturation and fertilization of oocytes from unstimulated ovaries: predicting the number of immature oocytes retrieved by early follicular phase ultrasonography. Am J Obstet Gynecol 2002; 186: 684–9.
7. LimKS, YoonSH, LimJH. IVM as an alternative for over-responders. In TanSL, ChianRC, BuckettW, eds. In-Vitro Maturation of Human Oocytes: Basic Science to Clinical Application. London: Informa Healthcare, 2007.
8. LiuJ, LuG, QianY, MaoY, DingW. Pregnancies and births achieved from in vitro matured oocytes retrieved from poor responders undergoing stimulation in in vitro fertilization cycles. Fertil Steril 2003; 80: 447–9.
9. LiuJ, LimJH, ChianRC. IVM as an alternative for poor responders. In TanSL, ChianRC, BuckettW, eds. In-Vitro Maturation of Human Oocytes: Basic Science to Clinical Application. London: Informa Healthcare, 2007; 333–44.
10. ChildTJ, GulekliB, ChianRC, Abdul-JalilAK, TanSL. In-vitro maturation (IVM) of oocytes from unstimulated normal ovaries of women with a previous poor response to IVF. Fertil Steril 2000; 74: S45.
11. HolzerH, ScharfE, ChianRC, et al. In vitro maturation of oocytes collected from unstimulated ovaries for oocyte donation. Fertil Steril 2007; 88: 62–7.
12. ElizurSE, ChianRC, HolzerHE, et al. Cryopreservation of oocytes in a young woman with severe and symptomatic endometriosis: a new indication for fertility preservation. Fertil Steril 2009; 91: 293 e1–3.
13. HuangJY, BuckettWM, GilbertL, TanSL, ChianRC. Retrieval of immature oocytes followed by in vitro maturation and vitrification: a case report on a new strategy of fertility preservation in women with borderline ovarian malignancy. Gynecol Oncol 2007; 105: 542–4.
14. LauNM, HuangJY, MacDonaldS, et al. Feasibility of fertility preservation in young females with Turner syndrome. Reprod Biomed Online 2009; 18: 290–5.
15. RaoGD, ChianRC, SonWS, GilbertL, TanSL. Fertility preservation in women undergoing cancer treatment. Lancet 2004; 363: 1829–30.
16. DemirtasE, ElizurSE, HolzerH, et al. Immature oocyte retrieval in the luteal phase to preserve fertility in cancer patients. Reprod Biomed Online 2008; 17: 520–3.
17. HuangJY, ChenHY, TanSL, ChianRC. Effect of choline-supplemented sodium-depleted slow freezing versus vitrification on mouse oocyte meiotic spindles and chromosome abnormalities. Fertil Steril 2007; 88: 1093–100.
18. HuangJY, ChenHY, ParkJY, TanSL, ChianRC. Comparison of spindle and chromosome configuration in in vitro- and in vivo-matured mouse oocytes after vitrification. Fertil Steril 2008; 90: 1424–32.
19. ChianRC, HuangJY, GilbertL, et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil Steril 2009; 91: 2391–8.
20. HuangJY, TulandiT, HolzerH, TanSL, ChianRC. Combining ovarian tissue cryobanking with retrieval of immature oocytes followed by in vitro maturation and vitrification: an additional strategy of fertility preservation. Fertil Steril 2008; 89: 567–72.
21. HuangJY, TulandiT, HolzerH, et al. Cryopreservation of ovarian tissue and in vitro matured oocytes in a female with mosaic Turner syndrome: case report. Hum Reprod 2008; 23: 336–9.
22. SonWY, ChungJT, HerreroB, et al. Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles. Hum Reprod 2008; 23: 2680–5.
23. SonWY, YoonSH, LimJH. Effect of gonadotrophin priming on in-vitro maturation of oocytes collected from women at risk of OHSS. Reprod Biomed Online 2006; 13: 340–8.
24. FadiniR, Dal CantoMB, Mignini RenziniM, et al. Effect of different gonadotrophin priming on IVM of oocytes from women with normal ovaries: a prospective randomized study. Reprod Biomed Online 2009; 19: 343–51.
25. MikkelsenAL, SmithSD, LindenbergS. In-vitro maturation of human oocytes from regularly menstruating women may be successful without follicle stimulating hormone priming. Hum Reprod 1999; 14: 1847–51.
26. MikkelsenAL, LindenbergS. Benefit of FSH priming of women with PCOS to the in vitro maturation procedure and the outcome: a randomized prospective study. Reproduction 2001; 122: 587–92.
27. GulekliB, BuckettWM, ChianRC, et al. Randomized, controlled trial of priming with 10,000 IU versus 20,000 IU of human chorionic gonadotropin in women with polycystic ovary syndrome who are undergoing in vitro maturation. Fertil Steril 2004; 82: 1458–9.
28. SonWY, ChungJT, ChianRC, et al. A 38 h interval between hCG priming and oocyte retrieval increases in vivo and in vitro oocyte maturation rate in programmed IVM cycles. Hum Reprod 2008; 23: 2010–6.
29. SonWY, ChungJT, DemirtasE, et al. Comparison of in-vitro maturation cycles with and without in-vivo matured oocytes retrieved. Reprod Biomed Online 2008; 17: 59–67.
30. SonWY, LeeSY, LimJH. Fertilization, cleavage and blastocyst development according to the maturation timing of oocytes in in vitro maturation cycles. Hum Reprod 2005; 20: 3204–7.
31. ChildTJ, GulekliB, SylvestreC, TanSL. Ultrasonographic assessment of endometrial receptivity at embryo transfer in an in vitro maturation of oocyte program. Fertil Steril 2003; 79: 656–8.
32. ChildTJ, Abdul-JalilAK, GulekliB, TanSL. In vitro maturation and fertilization of oocytes from unstimulated normal ovaries, polycystic ovaries, and women with polycystic ovary syndrome. Fertil Steril 2001; 76: 936–42.
33. ElizurSE, SonWY, YapR, et al. Comparison of low-dose human menopausal gonadotropin and micronized 17beta-estradiol supplementation in in vitro maturation cycles with thin endometrial lining. Fertil Steril 2009; 92: 907–12.
34. Soderstrom-AnttilaV, MakinenS, TuuriT, SuikkariAM. Favourable pregnancy results with insemination of in vitro matured oocytes from unstimulated patients. Hum Reprod 2005; 20: 1534–40.
35. BuckettWM, ChianRC, HolzerH, et al. Obstetric outcomes and congenital abnormalities after in vitro maturation, in vitro fertilization, and intracytoplasmic sperm injection. Obstet Gynecol 2007; 110: 885–91.
36. SonWY, LeeSY, YoonSH, LimJH. Pregnancies and deliveries after transfer of human blastocysts derived from in vitro matured oocytes in in vitro maturation cycles. Fertil Steril 2007; 87: 1491–3.
37. BuckettWM, ChianRC, DeanNL, et al. Pregnancy loss in pregnancies conceived after in vitro oocyte maturation, conventional in vitro fertilization, and intracytoplasmic sperm injection. Fertil Steril 2008; 90: 546–50.
38. Shu-ChiM, Jiann-LoungH, Yu-HungL, et al. Growth and development of children conceived by in-vitro maturation of human oocytes. Early Hum Dev 2006; 82: 677–82.
39. Soderstrom-AnttilaV, SalokorpiT, PihlajaM, Serenius-SirveS, SuikkariAM. Obstetric and perinatal outcome and preliminary results of development of children born after in vitro maturation of oocytes. Hum Reprod 2006; 21: 1508–13.
40. AoA, JinS, RaoD, et al. First successful pregnancy outcome after preimplantation genetic diagnosis for aneuploidy screening in embryos generated from natural-cycle in vitro fertilization combined with an in vitro maturation procedure. Fertil Steril 2006; 85: 1510 e9–11.
41. Abdul-JalilAK, ChildTJ, PhillipsS, et al. Ongoing twin pregnancy after ICSI of PESA-retrieved spermatozoa into in-vitro matured oocytes: case report. Hum Reprod 2001; 16: 1424–6.
42. HourvitzA, MamanE, BrengauzM, MachtingerR, DorJ. In vitro maturation for patients with repeated in vitro fertilization failure due to “oocyte maturation abnormalities”. Fertil Steril 2010; 94: 496–501.
43. Al-SunaidiM, TulandiT, HolzerH, et al. Repeated pregnancies and live births after in vitro maturation treatment. Fertil Steril 2007; 87: 1212 e9–12.